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bstract
bjective:  To characterize the interaction of phenolic (free and bound) extracts from white butterfly (Clerodendrum  volubile
. Beauv) leaves with key enzymes relevant to non-insulin dependent diabetes mellitus (-amylase and -glucosidase) and
ypertension (Angiotensin-I converting enzyme) and their antioxidant properties in  vitro.
ethods:  The effects of the extracts on enzymes [-amylase, -glucosidase, Angiotensin-I converting enzyme (ACE)], some pro-
xidant (Fe2+- and sodium nitroprusside-induced lipid peroxidation in the pancreas (in  vitro)) and antioxidant properties and HPLC
nalysis of the extracts were investigated.
esults:  The phenolic extracts inhibited -amylase, -glucosidase, ACE and some pro-oxidants (Fe2+- and sodium nitroprusside-
nduced lipid peroxidation in the pancreas (in  vitro)). Bound phenolics had significantly higher (P  < 0.05) -glucosidase inhibitory
ffects compared to free phenolics and acarbose (a standard drug). However, captopril, a synthetic ACE inhibitor, showed a higher
CE inhibitory activity compared with both the free and bound phenolics, whereas there was no significant difference (P  > 0.05)
n their -amylase inhibitory activities. The stronger inhibition of -glucosidase and ACE compared to -amylase by both extracts
ay be of pharmacological relevance. Reversed-phase HPLC analysis of the extracts revealed the presence of quercetin, rutin,
aempferol, and chlorogenic and caffeic acids as the main components of both the free and bound extracts.
onclusion:  The inhibitory properties of phenolic rich extracts on -amylase, -glucosidase, ACE, and Fe2+- and sodium
itroprusside-induced lipid peroxidation in the pancreas could be attributed to the antioxidant properties of the extracts and their
henolic composition. The stronger action of the bound phenolic extract on -glucosidase may provide the possible bioactivity at
s sugg
d hypertension.
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1.  Introduction
Reports by the World Health Organisation have
shown that non-insulin dependent diabetes mellitus
(NIDDM) and its complications are increasing in sub-
Saharan Africa and the prevalence of the disease is
increasing annually [1]. Central to the aetiology and
progression of NIDDM is hyperglycemia. Inhibition of
key enzymes (-glucosidase and -amylase) involved
in starch digestion is considered to be one of the prac-
tical strategies for the management of hyperglycaemia.
Drugs, such as acarbose, miglitol, voglibose, nojirimycin
and 1-deoxynojirimycin, are currently in use; however,
they are quite expensive and their side effects are unbear-
able for patients. In recent years, the potential sources of
glucosidase inhibitors from plants have been extensively
studied and have resulted in the discovery and devel-
opment of several natural inhibitors with anti-diabetic
effects.
Hypertension or high blood pressure is a common
cardiovascular disease, which has become a worldwide
problem of epidemic proportions and affects 15–20%
of all adults with ailments such as arteriosclerosis,
stroke, myocardial infarction and end-stage renal disease
[2]. It is regarded as one of the long-term compli-
cations of NIDDM. These two diseases (hypertension
and NIDDM) are interrelated metabolic disorders with
persistent hypertension serving as a risk factor for
stroke and the leading cause of chronic renal failure
[3]. Angiotensin-I converting enzyme (ACE) is the key
enzyme responsible for the regulation of blood pressure.
It converts angiotensin I to angiotensin II, which is a
potent vasoconstrictor. The inhibition of ACE activity
may provide an antihypertensive potential by the con-
current lowering of the blood pressure in diabetic and
non-diabetic patients [4]. Drugs, such as lisinopril, cap-
topril and enalapril, are currently in use as ACE inhibitors
and have been reported to be safe and effective. In the
continued search for ACE inhibitors, dietary phenolic
phytochemicals have been shown to have promising
potential [5].
In recent decades, the consumption of vegetables has
attracted growing interest because many experimental
and epidemiological studies have consistently demon-
strated a positive correlation between the intake of these
natural food products and reduced risks of several degen-
erative diseases, including NIDDM [5,6]. The protection
provided by the intake of vegetables and vegetable-
rich foods against these debilitating diseases has been
attributed to the presence of several antioxidants, espe-
cially antioxidative vitamins, including ascorbic acid
(vitamin C), -tocopherol (vitamin E) and -caroteneiversity for Science 10 (2016) 521–533
(provitamin A). Nevertheless, recent studies seem to
indicate that polyphenolic substances are the main phy-
tochemicals, with higher antioxidant properties found in
plants [5,6].
Phenolics in vegetables may be present in free or
aglycone and bound or glycoside forms [6]. The free
phenolics are more readily absorbed and thus may exert
beneficial bioactivities during food digestion. However,
the significance of bound phenolics to human health is
not well understood [7], and it is possible that different
plant foods with different amounts of bound pheno-
lics can be digested and absorbed at different sites
of the gastrointestinal tract where they perform their
unique health roles. Bound phenolics are mainly found
in -glycosides, and they are not digestible by human
enzymes and thus could survive stomach and small intes-
tine digestion to reach the colon. In the colon they
are digested by bacteria flora to release phytochemicals
locally and result in health benefits.
White butterfly (Clerodendrum  volubile  P. Beauv)
leaf is a climbing shrub that is commonly grown in decid-
uous forests across Africa and belongs to the Family
Verbenaceae [8]. In the southern part of Nigeria, which
is highly dominated by the Ijaws, Urhobos and Itsekiris,
it is well-known as a delicious green leafy vegetable
that is commonly consumed as food and medicine in
folklore for the management of arthritis, rheumatism,
dropsy, swellings, oedema, and gout and is also used as
an anti-abortifacient and sedative [8,9]. The high nutri-
tional qualities of green leafy vegetables were reported
by Erukainure et al. [9]. In another study by Fred-
Jaiyesimi and Adekoya [10], the presence of various
phytochemicals, such as alkaloids, flavonoids, saponins,
anthraquinone and cardiac glycoside, were reported. The
anti-inflammatory effects of the leaf extracts were also
documented [10]. Moreover, there is a dearth of informa-
tion on the antioxidant, antidiabetic and antihypertensive
effects of the green leafy vegetable. Therefore, this study
was planned to investigate the antioxidant effect and pos-
sible inhibition against key enzymes (-amylase and
-glucosidase) relevant to NIDDM and hypertension
(Angiotensin-I converting enzyme).
2.  Materials  and  methods
Sample  collection: A fresh sample of white butter-
fly (C.  volubile  P. Beauv) leaf was purchased from the
Erekesan market in Akure metropolis, Nigeria. Authenti-
cation of the leaves was conducted by Dr. A.A. Sorungbe
(a taxonomist) in the Department of Biology, Federal
University of Technology, Akure, Nigeria and assigned a
voucher number (FUTA/BIO/0121). The vegetable was
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insed under tap water, washed twice with double dis-
illed water and air dried on paper towels for 7 days. The
dible portions were separated from the inedible portion.
he edible portions were chopped into nearly equal small
ieces or slices and mixed well. The initial weight of the
liced vegetable sample was collected before it was air
ried at room temperature. The dried vegetable sample
as later powdered in a Willey 60 mesh size and stored
n the refrigerator before phenolic extraction.
.1.  Extraction  of  phenolics
Extraction  of  free  phenolics: The free phenolic extrac-
ion was conducted according to a modified method
eported by Chu et al. [7]. One-hundred grams each of
he powdered spice samples were extracted with 80%
cetone (1:5, w/v) and filtered (Whatman No. 2 filter
aper) under a vacuum. The filtrate was then evaporated
sing a rotary evaporator under a vacuum at 45 ◦C until
pproximately 90% of the filtrate had been evaporated
nd then lyophilized to obtain a dry extract. The extract
as kept at −4 ◦C prior to analysis, whereas the residues
ere kept for bound phenolic extraction.
Extraction of  bound  phenolics: The residue from the
ree extraction above was flushed with nitrogen and
ydrolyzed with approximately 20 mL of a 4 M NaOH
olution at room temperature for 1 h with shaking. Then,
he pH of the mixture was adjusted to 2 with concentrated
Cl and the bound phytochemicals were extracted with
thylacetate (6 times). The ethyl acetate extracts were
hen evaporated until dry at 45 ◦C and according to the
ethod described by Chu et al. [7].
.2.  Enzyme  assay
α-Amylase  assay: The -amylase assay was per-
ormed according to the method described by Worthing-
on [11]. The aqueous extract dilution (500 L) of the
owdered leaves and 500 L of 0.02 mol/L sodium phos-
hate buffer (pH 6.9 with 0.006 mol/L NaCl) containing
og pancreatic -amylase (EC 3.2.1.1) (0.5 mg/mL)
as incubated at 25 ◦C for 10 min. Then, 500 L of
 1% starch solution in 0.02 mol/L sodium phosphate
uffer (pH 6.9 with 0.006 mol/L NaCl) was added to the
eaction mixture. Thereafter, the reaction mixture was
ncubated at 25 ◦C for 10 min and stopped with 1.0 mL of
 dinitrosalicylic acid (DNSA) colour reagent. The mix-
ure was then incubated in a boiling water bath for 5 min
nd cooled to room temperature. Acarbose was used as
 positive control in the experiment. The reaction mix-
ure was then diluted by adding 10 mL of distilled water,
nd the absorbance measured at 540 nm in a UV–visiversity for Science 10 (2016) 521–533 523
spectrophotometer (Model 6305; Jenway, Barloworld
Scientific, Dunmow, United Kingdom). The -amylase
inhibitory activity was expressed as the percentage inhi-
bition.
% Inhibition = Absref −  Abssam
Absref
×  100
where Absref is the absorbance of reference and Abssam
is the absorbance of sample.
α-Glucosidase  assay: The -glucosidase assay was
performed according to the method described by Apos-
tolidis et al. [12]. The appropriate dilution of the
aqueous extracts (50 L) of spices and 100 L of an
-glucosidase solution (1.0 U/mL) in 0.1 mol/L phos-
phate buffer (pH 6.9) was incubated at 25 ◦C for
10 min. Thereafter, 50 L of 5 mmol/L p-nitrophenyl-
-d-glucopyranoside solutions in 0.1 mol/L phosphate
buffer (pH 6.9) was added. The reaction mixture was
then incubated at 25 ◦C for 5 min, and the absorbance
was then measured at 405 nm in a UV–vis spectropho-
tometer (Model 6305; Jenway, Barloworld Scientific,
Dunmow, United Kingdom). Acarbose was used as a
positive control in the experiment. The -glucosidase
inhibitory activity was expressed as the percentage inhi-
bition.
% Inhibition = Absref −  Abssam
Absref
×  100
where Absref is the absorbance of reference and Abssam
is the absorbance of sample.
Angiotensin  I-converting  enzyme  (ACE)  inhibition
assay: The ACE activity was measured using a
chromatographic method that was developed from a
spectrophotometric method [13]. THE phenolic extracts
(0–50 L) were dissolved in HEPES buffer [50 mM N-
2-hydroxyethylpiperazine-N-2-ethanesulfonic acid and
300 mM NaCl at pH 8.3], and appropriate volumes
were chosen to achieve concentrations in the enzymatic
assay ranging between 0.005 and 1.5 mg/mL. In each
well of a 96-well microtiter plate (Brand), 10 L of
an inhibitor solution was mixed with 10 L of ACE
from rabbit lung (Sigma-Aldrich) dissolved to reach an
activity of 0.4 mU/mL in bidistilled water. Each verti-
cal row of the plate had a negative control, which was
prepared by replacing the inhibitor solution by 10 L of
water. The mixture was preincubated for 10 min at 37 ◦C.
Eighty microliters of a 5 mM solution of the synthetic
substrate hippuryl-histidyl-leucine (HHL) dissolved in
HEPES buffer [50 mM N-2-hydroxyethylpiperazine-N-
2-ethanesulfonic acid and 300 mM NaCl at pH 8.3] was
added. The system was incubated for 120 min at 37 ◦C.
The reaction was terminated by adding 100 L of 1 M
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HCl. The amount of enzymatically liberated hippuric
acid was measured via  reversed-phase high performance
liquid chromatography (RP-HPLC). The HPLC system
was Smartline and composed of a Manager 5000, Pump
1000, UV Detector 2600, Autosampler 3950, and col-
umn oven (Knauer). The column was a C18-Eurosphere
100, with dimensions of 5 m, 250 mm, and 4.6 mm,
from the same company. The column temperature was
set at 25 ◦C. A total of 30 L of the sample was injected.
Elution was achieved with a gradient of a 0.1% formic
acid aqueous solution (solvent A) and 0.1% formic acid
in methanol (solvent B) at a flow rate of 1 mL/min. The
gradient was as follows: 2 min at 15% solvent B, 15–25%
solvent B for 8 min, 25–80% solvent B for 11 min, 1 min
at 80% solvent B, 80–15% solvent B for 2 min and equil-
ibration for 3 min at 15% solvent B. Hippuric acid was
detected at 228 nm (8.9 min elution time). The evaluation
software was ChromGate V3.3.1 (Knauer). The product
peak was integrated to calculate the ACE activity in the
absence or presence of inhibitors. Captopril was used
as a positive control in the experiment. The inhibitory
activities were later expressed as the percentage inhibi-
tion. The IC50 (inhibitor concentrations needed for 50%
inhibition) of ACE activity was subsequently calculated.
% Inhibition = Absref −  Abssam
Absref
×  100
where Absref is the absorbance of reference and Abssam
is the absorbance of sample.
Determination  of  the  total  phenol  content: The total
phenol content was determined on the extracts using the
method reported by Singleton et al. [14]. Dilutions of
the extracts were oxidized with 2.5 mL of 10% Folin-
Ciocalteau’s reagent (v/v) and neutralized with 2.0 mL
of 7.5% sodium carbonate. The reaction mixture was
incubated for 40 min at 45 ◦C, and the absorbance was
measured at 765 nm in a UV–vis spectrophotometer
(Model 6305, Barloworld Scientific, Dunmow, Essex,
United Kingdom). The total phenol content was subse-
quently calculated using gallic acid as the standard.
Determination  of the  total  ﬂavonoid  content: The total
flavonoid content of the spice extracts was determined
using a slightly modified method reported by Meda et al.
[15]. Briefly, 0.5 mL of the appropriately diluted sam-
ple was mixed with 0.5 mL of methanol, 50 L of 10%
AlCl3, 50 L of 1 mol/L potassium acetate and 1.4 mL
of water and allowed to incubate at room temperature for
30 min. Thereafter, the absorbance of the reaction mix-
ture was subsequently measured at 415 nm in a Jenway
UV–vis spectrophotometer. The total flavonoid content
was calculated using quercetin as the standard.iversity for Science 10 (2016) 521–533
HPLC-DAD  analyses: Reverse phase chromato-
graphic analyses were conducted under gradient
conditions using a C18 column (4.6 mm ×  250 mm)
packed with 5-m diameter particles; the mobile phase
was water containing 2% acetic acid (A) and methanol
(B); and the composition gradient was: 5% of B until
2 min and then changed to obtain 25%, 40%, 50%,
60%, 70% and 100% B at 10, 20, 30, 40, 50 and 80 min,
respectively, following the method described by Laghari
et al. [16] with slight modifications. Bound and free
extracts of C.  volubile  were analyzed at a concentra-
tion of 10 mg/mL. The presence of some antioxidant
compounds was investigated, namely, chlorogenic and
caffeic acids, as well as quercetin, rutin and kaempferol.
The identification of these compounds was performed
by comparing their retention time and UV absorption
spectrum with those of the commercial standards. The
flow rate was 0.7 mL/min, with an injection volume of
50 L, and the wavelengths were 325 nm for chloro-
genic and caffeic acids and 365 nm for quercetin, rutin
and kaempferol. All of the samples and the mobile
phase were filtered through a 0.45-m membrane filter
(Millipore) and then degassed using an ultrasonic bath
prior to use. Stock solutions of the reference standards
were prepared in the HPLC mobile phase at a con-
centration range of 0.020–0.200 mg/mL for quercetin,
rutin and kaempferol, and 0.050–0.250 mg/mL for
chlorogenic and caffeic acids. The chromatography
peaks were confirmed by comparing the retention time
with those of the reference standards and by DAD
spectra (200–600 nm). A calibration curve was created
for chlorogenic acid: Y  = 12,165x  + 1347.5 (r  = 0.9999);
caffeic acid: Y  = 12,405x  + 1281.6 (r  = 0.9995);
rutin: Y  = 12,791x  + 1162.5 (r  = 0.9998); quercetin:
Y = 11,375x  + 1265.9 (r  = 0.9996); and kaempferol:
Y = 13,964x  + 1253.7 (r = 0.9999). All of the chro-
matography operations were conducted at ambient
temperature and in triplicate.
2.3.  Antioxidant  assays
DPPH  free  radical  scavenging  ability: The free
radical-scavenging ability of the spice extracts against
the DPPH (1,1-diphenyl-2-picrylhydrazyl) free radical
was evaluated as described by Gyamfi et al. [17]. Briefly,
an appropriate dilution of the spice extracts (1 mL) was
mixed with 1 mL of a 0.4 mmol/L methanol solution con-
taining DPPH radicals. The mixture was left in the dark
for 30 min, and the absorbance was measured at 516 nm
in the UV–vis spectrophotometer (Model 6305; Jenway,
Barloworld Scientific, Dunmow, United Kingdom). The
DPPH free radical scavenging ability was subsequently
bah Un
c
a
D
w
i
m
d
r
t
t
d
o
w
t
r
2
t
t
2
s
c
m
m
o
r
(
T
a
T
i
s
o
s
n
a
c
fi
1
f
n
w
l
w
u
mS.A. Adefegha, G. Oboh / Journal of Tai
alculated with respect to the reference, which contained
ll of the reagents without the test sample.
PPH radical scavenging ability (%)
= Absref −  Abssam
Absref
×  100
here Absref is the absorbance of reference and Abssam
s the absorbance of sample.
Hydroxyl  (OH)  radical  scavenging  ability: The
ethod of Halliwell and Gutteridge [18] was used to
etermine the ability of the extracts to scavenge OH
adicals produced by Fe2+/H2O2-induced decomposi-
ion of deoxyribose. The extract (0–100 L) was added
o a reaction mixture containing 120 L of 20 mM
eoxyribose, 400 L of 0.1 M phosphate buffer, 40 L
f 500 M of freshly prepared FeSO4, and the volumes
ere brought up to 800 L with distilled water. The reac-
ion mixture was incubated at 37 ◦C for 30 min, and the
eaction was then stopped by the addition of 0.5 mL of
8% trichloroacetic acid. This was followed by the addi-
ion of 0.4 mL of a 0.6% thiobarbituric acid solution. The
ubes were subsequently incubated in boiling water for
0 min. The absorbance was measured at 532 nm in a
pectrophotometer.
Determination of  Fe2+ chelating  ability: The Fe2+
helating ability of the extracts was determined using a
odified method of Minotti and Aust [19] with a slight
odification by Puntel et al. (2005). A total of 500 M
f freshly prepared FeSO4 (150 L) was added to a
eaction mixture containing 168 L of 0.1 M Tris–HCl
pH 7.4), 218 L of saline and the extracts (0–25 L).
he reaction mixture was incubated for 5 min before the
ddition of 13 L of 0.25% 1,10-phenanthroline (w/v).
he absorbance was subsequently measured at 510 nm
n a spectrophotometer. The Fe2+ chelating ability was
ubsequently calculated.
Handling  and  use  of  the  animal: Approval was
btained from the University ethics committee respon-
ible for the use of laboratory animals with reference
umber FUTA/SOS/1407. The handling and use of the
nimals were in accordance with the NIH Guide for the
are and use of laboratory animals. In the experiment,
ve adult male Wistar strain albino rats of approximately
8–22 weeks old weighing 170–190 g were purchased
rom the breeding colony of the Department of Veteri-
ary Medicine, University of Ibadan, Nigeria. The rats
ere maintained at room temperature (25 ◦C) on a 12 hight/12 h dark cycle with free access to food and water. A
arming and cooling system with good ventilation was
sed for the maintenance of temperature at 25 ◦C. A ther-
ometer was used to measure the temperature change.iversity for Science 10 (2016) 521–533 525
The temperature was monitored within the cage and at
various positions within the room to monitor variation
to optimally manage the microenvironment. The relative
humidity at the level of the rat cages was kept at 45–55%.
The number of air changes per hour was adjusted to keep
the air quality, temperature and humidity at acceptable
levels within the cages. They were acclimatized under
these conditions for 3 weeks before the commencement
of the experiments.
2.4.  Lipid  peroxidation  assay
Preparation  of  tissue  homogenates: The rats were
decapitated under mild diethyl ether anaesthesia, and the
pancreas was rapidly excised, placed on ice and weighed.
This tissue was subsequently homogenized in cold saline
(1/10, w/v) with approximately 10 up and down strokes
at approximately 1200 rpm in a Teflon glass homoge-
nizer. The homogenate was centrifuged for 10 min at
3000 × g  to yield a pellet that was discarded, and a low-
speed supernatant (S1) containing mainly water, proteins
and lipids (cholesterol, galactolipid, individual phospho-
lipids, gangliosides) was kept for the lipid peroxidation
assay [20].
% Inhibition = Absref −  Abssam
Absref
×  100
where Absref is the absorbance of reference and Abssam
is the absorbance of sample.
Lipid  peroxidation  and  thiobarbituric  acid  reactions:
The lipid peroxidation assay was conducted by the mod-
ified method of Ohkawa et al. [21] Briefly, 100 L of
the S1 fraction was mixed with a reaction mixture con-
taining 30 L of 0.1 M Tris–HCl buffer (pH 7.4), extract
(0–100 L) and 30 L of the pro-oxidant (250 M of
freshly prepared FeSO4 and 7 M sodium nitroprus-
side). The volume was brought up to 300 L with water
before incubation at 37 ◦C for 2 h. The colour reac-
tion was developed by adding 300 L of 8.1% SDS
(sodium dodecyl sulphate) to the reaction mixture con-
taining S1, followed by the addition of 600 L of acetic
acid/HCl (pH 3.4) and 600 L of 0.8% TBA (thiobar-
bituric acid). This mixture was incubated at 100 ◦C for
1 h. The absorbance of the TBARS (thiobarbituric acid
reactive species) produced were measured at 532 nm
in a UV–vis spectrophotometer (Model 6305; Jenway,
Barloworld Scientific, Dunmow, United Kingdom). The
MDA (malondialdehyde) produced was expressed as %
Control.
Data  analysis: The result of the replicates were
pooled and expressed as the mean ±  standard deviation
[22]. One-way analysis of variance (ANOVA) and the
bah Un526 S.A. Adefegha, G. Oboh / Journal of Tai
least significance difference (LSD) were conducted, and
the significance was accepted at P  ≤  0.05.
3.  Results
This study investigated the ability of the phenolic
extract of white butterfly leaf to inhibit -amylase and
-glucosidase (key enzymes linked to NIDDM), and
the results are presented in Figs. 1 and 2. From the
results, the phenolic extracts (free and bound) inhibited
-amylase in a concentration dependent manner (Fig. 1).
However, judging from the IC50 (extract concentration
causing 50% enzyme inhibition), there was no sig-
nificant (P  > 0.05) difference between the -amylase
inhibitory effects of the free soluble phenolic extract
(IC50 = 169.5 g/mL) and the bound phenolic extract
(IC50 = 178.6 g/mL). Furthermore, both the free solu-
ble and bound phenolic extracts inhibited -glucosidase
activity in a concentration dependent manner. How-
ever, the bound phenolic extracts (IC50 = 13.29 g/mL)
had a significantly (P  < 0.05) higher inhibitory effect
Fig. 1. Inhibitory activities of phenolic extracts from white butter-
fly (Clerodendrum volubile P. Beauv) leaf against alpha-amylase. The
values are represented as the mean ± standard deviation of triplicate
experiments.
Fig. 2. Inhibitory activities of phenolic extracts from white butterfly
(Clerodendrum volubile P. Beauv) leaf against alpha-glucosidase. The
values are represented as the mean ± standard deviation of triplicate
experiments.iversity for Science 10 (2016) 521–533
against -glucosidase activity than the free soluble
phenolic extracts (IC50 = 30.43 g/mL). The phenolic
extracts showed a significantly (P  < 0.05) higher inhibi-
tion of -amylase and -glucosidase activities compared
with acarbose [-amylase (IC50 = 381.23 g/mL) and -
glucosidase (IC50 = 309.52 g/mL)].
Additionally, the ACE inhibitory effect of the phe-
nolic extracts (free and bound) was also investigated,
and the results are presented in Fig. 3. Both the free
soluble and bound phenolic extracts inhibited ACE in
a dose dependent manner. However, the bound pheno-
lic extracts (IC50 = 0.61 mg/mL) exhibited a significantly
(P < 0.05) higher inhibitory effect than the free soluble
phenolic extract (IC50 = 2.70 mg/mL). However, capto-
pril (IC50 = 0.02 mg/mL) exhibited a stronger inhibition
of ACE activity than C.  volubile  phenolics. A strong cor-
relation exists between the enzyme inhibitory activities
and the phenolic content of the extracts [-amylase inhi-
bition: free soluble phenolic extract (r2 = 0.9546), bound
phenolic extract (r2 = 0.9440); -glucosidase inhibition:
free soluble phenolic extract (r2 = 0.9638), bound pheno-
lic extract (r2 = 0.9377); and ACE inhibition: free soluble
phenolic extract (r2 = 0.9591), bound phenolic extract
(r2 = 0.9768)].
Subsequently, the results of the quantification of the
total phenolic (reported as gallic acid equivalent-GAE)
and total flavonoid (reported as quercetin equivalent-
QEAC) contents of the white butterfly leaf extract are
presented in Table 1. The total phenolic content showed
significantly (P  < 0.05) higher free soluble phenolics
(10.20 mg GAE/g) than the bound phenolics (6.90 mg
GAE/g). Similarly, the total flavonoid content also
reported a higher amount of free soluble phenolics
(6.80 mg QEAC/g) than the bound phenolics (4.60 mg
QEAC/g).
Fig. 3. Inhibitory activities of phenolic extracts from white butterfly
(Clerodendrum volubile P. Beauv) leaf against Angiotensin-I convert-
ing enzyme (ACE). The values are represented as the mean ± standard
deviation of triplicate experiments.
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Fig. 4. Representative high performance liquid chromatography profile of Clerodendrum volubile, CVB (A) and COV (B); the detection UV was at
325 nm. The numbers represent chlorogenic acid (peak 1), caffeic acid (peak 2), rutin (peak 3), isoquercitrin (peak 4), quercitrin (peak 5), quercetin
(peak 6) and kaempferol (peak 7). The chromatographic conditions are described in Section 2.
Table 1
Total phenol and total flavonoids (mg/100 g) of phenolic extracts of
white butterfly leaf.
Total phenol (mg
gallic acid
equivalent/g)
Total flavonoid
(mg quercetin
equivalent/g)
Free phenolics 10.2 ± 0.8b 6.8 ± 0.3b
Bound phenolics 6.9 ± 0.2a 4.6 ± 0.5a
Values represent the mean ± standard deviation of triplicate readings.
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Fig. 5. The DPPH free radical scavenging ability of phenolic extracts
from white butterfly (Clerodendrum volubile P. Beauv) leaf. The values
are represented as the mean ± standard deviation of triplicate experi-
ments.alues with the same superscript letter on the same column are not
ignificantly (P > 0.05) different.
HPLC fingerprinting of C.  volubile  phenolic extracts
free and bound) (Fig. 4) revealed the presence of
hlorogenic acid (tR = 22.83 min; peak 1), caffeic acid
tR = 29.05 min; peak 2), rutin (tR = 39.17 min; peak
), isoquercitrin (tR = 46.13 min; peak 4), quercitrin
tR = 51.26 min; peak 5), quercetin (tR = 57.89 min; peak
) and kaempferol (tR = 68.01 min; peak 7) (Fig. 8
nd Table 3). HPLC analysis revealed that flavonoids
quercetin, rutin and kaempferol) and phenolics acids
chlorogenic and caffeic acids) are the major components
f the extract.
The free radical scavenging abilities of the pheno-
ic extracts of white butterfly leaf were investigated
sing different in  vitro  models. The DPPH and OH rad-
cal scavenging abilities of the phenolic extracts and
he results are presented in Figs. 5 and 6. The results
howed that both the free soluble and bound phenolic
xtracts scavenged DPPH free radicals in a concen-
ration dependent manner. However, the IC50 values
Table 2) revealed that the free soluble phenolic extract
IC50 = 89.18 g/mL) had a significantly (P  < 0.05)
igher scavenging ability against DPPH free radicals
han the bound phenolic extracts (133.40 g/mL). Sim-
larly, both free soluble and bound phenolic extracts
cavenged OH radicals (Fig. 6) in a concentration-
ependent manner. However, the free soluble phenolicFig. 6. The OH radical scavenging ability of phenolic extracts from
white butterfly (Clerodendrum volubile P. Beauv) leaf. The values are
represented as the mean ± standard deviation of triplicate experiments.
extracts (IC50 = 924.90 g/mL) had a higher significant
(P < 0.05) scavenging ability than the bound phenolic
extracts (IC50 = 1224.0 g/mL).
The ability of the phenolic extracts to chelate Fe2+
was assessed, and the results (Fig. 7) showed that the
phenolic (free and bound) extracts chelated Fe2+ in a con-
centration dependent manner (0–80 g/mL). The free
soluble phenolic extract (IC50 = 146.90 g/mL) had a
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Table 2
IC50 values for the antioxidant properties, inhibition of lipid peroxidation and enzyme inhibitory ability of phenolic extracts of white butterfly leaf.
IC50 values
Free Bound Acarbose Captopril
-amylase inhibition (g/mL) 169.50a 178.60a 381.23b –
-glucosidase inhibition (g/mL) 30.43b 13.29a 309.52c –
ACE inhibition (mg/mL) 2.70c 0.61b – 0.02a
DPPH free radical scavenging ability (g/mL) 89.18a 133.40b – –
OH radical scavenging ability (g/mL) 924.90a 1224.00b – –
Fe2+ chelating ability (g/mL) 146.90a 641.70b – –
Values represent the mean triplicate readings. Values with the same superscript letter on the same row are not significantly (P > 0.05) different.
Table 3
Phenolic composition of Clerodendrum volubile by HPLC-DAD.
Compounds Clerodendrum volubile
Bound Free
mg/g Percent mg/g Percent
Chlorogenic acid 7.38 ± 0.03a 0.73 2.16 ± 0.01a 0.21
Caffeic acid 41.59 ± 0.02b 4.15 24.53 ± 0.02b 2.45
Rutin 6.82 ± 0.04a 0.68 6.01 ± 0.03cd 0.60
Isoquercitrin* 49.16 ± 0.01c 4.91 27.34 ± 0.0b 2.73
Quercitrin* 21.64 ± 0.01d 2.16 9.57 ± 0.04d 0.95
Quercetin 12.35 ± 0.02e 1.23 4.29 ± 0.01c 0.42
Kaempferol 17.49 ± 0.03d 1.74 – –
The results are expressed as the mean ± standard deviation (SD) of three determinations. Different letters in each column represent significant
differences using an analysis of variance followed by Tukey’s test (P < 0.05).
* Quantified as quercetin.
Fig. 7. The Fe2+ chelating ability of phenolic extracts from white
Fig. 8. Inhibition of Fe2+ induced lipid peroxidation in the rat pan-
dependent manner (0–312.60 g/mL). The free solublebutterfly (Clerodendrum volubile P. Beauv) leaf. The values are repre-
sented as the mean ± standard deviation of triplicate experiments.
significantly (P  < 0.05) higher Fe2+ chelating ability than
the bound phenolic extracts (IC50 = 641.70 g/mL).
The ability of the phenolic extracts (free and bound) of
the white butterfly leaf to inhibit Fe2+ and SNP-induced
pancreatic lipid peroxidation in rats (in  vitro) are pre-
sented in Figs. 8 and 9. Incubation of the rat pancreascreas by phenolic extracts from white butterfly (Clerodendrum volubile
P. Beauv) leaf. The values are represented as the mean ± standard
deviation of triplicate experiments.
in the presence of Fe2+ caused a significant (P  < 0.05)
elevation in the malondialdehyde (MDA) content. How-
ever, the phenolic extracts (free and bound) were able to
significantly (P  < 0.05) reduce the MDA content in a dosephenolic extracts (192.30–77.90%) had a significantly
(P < 0.05) higher concentration-dependent inhibition of
MDA compared with that of the bound phenolic extract
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Fig. 9. Inhibition of sodium nitroprusside induced lipid peroxidation
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endrum volubile P. Beauv) leaf. The values are represented as the
ean ± standard deviation of triplicate experiments.
192.30–91.30%). Similarly, 7 M SNP incubated with
he rat pancreas also induced lipid peroxidation by a sig-
ificant MDA content elevation (134.70%). However,
he presence of phenolic extracts (free and bound) of
he white butterfly leaf significantly (P  < 0.05) reduced
he MDA content (free soluble extract = 134.70–66.50%;
ound phenolic = 134.70–81.70%) in a dose dependent
anner (0–312.60 g/mL).
.  Discussion
Minimizing postprandial hyperglycemia has been
eported to be an effective way of managing diabetes
ellitus, especially in NIDDM patients [23]. This can
e achieved by inhibiting carbohydrate hydrolysing
nzymes (-amylase and -glucosidase) in the gastroin-
estinal tract [24]. The ability of plant phenolic extracts
o inhibit -amylase and -glucosidase in  vitro  have
een well reported [25–27] and agrees with the findings
f this study that phenolic extracts (free and bound) of
he white butterfly flower significantly (P  < 0.05) inhibit
-amylase and -glucosidase (in  vitro) in a concentra-
ion dependent manner. The non-significant (P  > 0.05)
ifference in the -amylase inhibitory effect between
he free soluble phenolic and the bound phenolic extracts
f the white butterfly leaf may indicate that both phen-
lics are good inhibitors of the enzymes. This result
grees with earlier findings that Allium  spp. inhibited
-amylase activity in  vitro  [28]. Similarly, the pheno-
ic extracts of white butterfly leaf inhibited the activity
f -glucosidase (in  vitro) in a concentration depend-
nt manner, with the bound phenolic extracts showing significantly (P  < 0.05) higher inhibitory effect than
he free soluble extracts. However, it is noteworthy that
he phenolic extracts (free and bound) of white butter-
y leaf had a significantly (P  < 0.05) higher inhibitoryiversity for Science 10 (2016) 521–533 529
effect on -glucosidase than -amylase. This result is
in concordance with earlier reports, which showed that
plant phenolic extracts show higher inhibitory effects
on -glucosidase than -amylase [29,30]. The observed
-amylase and -glucosidase inhibitory properties of the
phenolic extracts from C.  volubile  may help to minimize
some side effects, such as flatulence, abdominal disten-
tion, meteorism and diarrhoea, that are associated with
synthetic drugs targeted towards the inhibition of these
key enzymes (-glucosidase and -amylase). Further-
more, other studies have established the link between
the enzyme inhibitory effects of plant extracts and their
phenolic contents [6,25]. This agrees with our findings
in which there was agreement between the phenolic
(free and bound) extracts of white butterfly leaf and
their alpha amylase inhibitory effects. The free soluble
phenolic extract had higher phenolic content than the
bound phenolic extract. The higher inhibitory effect of
-amylase and -glucosidase activities by the phenolic
extracts compared with acarbose may suggest C.  volubile
as a natural, alternative and complementary agent. This
observation may possibly confer greater advantages on
plant polyphenols in managing NIDDM rather than cur-
rently used synthetic drugs. This occurs more so because
current synthetic drugs used to lower postprandial hyper-
glycemia (such as acarbose) are stronger inhibitors of
-amylase. This has been proposed to lead to an exten-
sive inhibition of pancreatic -amylase, which results in
the anomalous fermentation of undigested saccharides
by bacteria in the colon and results in several compli-
cations, such as abdominal distention, flatulence, and
possibly diarrhoea [25]. Therefore, the ability of phe-
nolic extracts to mildly inhibit -amylase activity and
strongly inhibit the activity of -glucosidase may explain
the potency of white butterfly leaf in the management of
diabetes in folklore medicine, with no significant side
effect. In agreement with our earlier report on the effi-
cacy of phenolic extract (free and bound) of clove bud
(Syzygium aromaticum) in the reduction of postpran-
dial hyperglycemia by inhibition of alpha amylase and
alpha glucosidase [25], we propose the use of phenolic
extracts of white butterfly leaf as an alternative therapy
for reducing postprandial hyperglycemia and hence the
management of NIDDM.
Inhibition of ACE has been well established as being
effective in lowering blood pressure and for the manage-
ment of hypertension [2,31]. The association between
phenolic phytochemicals and inhibition of ACE has
been previously reported [32]. ACE is a metallopro-
tein with zinc metal present at the catalytic site. It has
been proposed that the ability of phenolics to chelate
transition metal ion (zinc) at the enzyme’s catalytic site
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[33] and/or form hydrogen bridges between active site
amino acid residues and phenolic phytochemicals are
possible mechanisms of ACE inhibition [33]. The phe-
nolic extracts (free and bound) of the white butterfly
leaf were able to inhibit ACE activity in  vitro. How-
ever, the bound phenolic extract showed significantly
(P < 0.05) higher ACE inhibition than the free soluble
phenolic extract. This result is in agreement with earlier
findings [34,35]. It is noteworthy that the ACE inhibitory
effects of the phenolic extracts (free and bound) of the
white butterfly leaf correlates with their alpha glucosi-
dase inhibitory effects, but not with the alpha amylase
inhibitory effects and the antioxidant activities. Hence,
in a similar manner, the observed higher ACE inhibitory
effect observed in bound phenolic extracts over the free
soluble phenolic extracts could be due to the presence
of non-phenolic ACE inhibitory compounds vis-à-vis
the possibility of synergistic effects of the bound phy-
tochemicals to elicit these observations. Additionally,
captopril showed a stronger inhibition of ACE activity
than C.  volubile  phenolics. However, the ACE inhibitory
effects of the phenolic extracts (free and bound) could
help explain the biochemical rationale behind the use of
white butterfly leaf for the prevention and management
of hypertension in traditional medicine.
Polyphenols, especially flavonoids, have been
reported to have enzyme (alpha amylase, alpha glucosi-
dase and ACE) inhibitory and antioxidant properties
[6,25,32,36]. This observation could be a result of
the structure–function relationship of these bioactive
compounds. Therefore, this study sought to quan-
tify the total phenolic and total flavonoid contents of
white butterfly leaf extracts. The results revealed a
significantly (P  < 0.05) higher content of free soluble
phenols (10.20 mg GAE/g) than bound phenols (6.90 mg
GAE/g). Similarly, the total flavonoid contains a higher
amount of free soluble phenols (6.80 mg QEAC/g) over
bound phenols (4.60 mg QEAC/g). This is in agreement
with an earlier report by Sun et al. [37], which revealed
that free soluble phenols are more abundant in some plant
foods than bound phenolics. While little is known about
the nutraceutical benefits of bound phenols, free soluble
phenols have a comparative advantage of being absorbed
at an early digestion stage to elicit their health bene-
fits [7,25,37]. Part of the enigma of bound phenols is
their inability to be digested by humans. Notwithstand-
ing, it is proposed that bound phenols, which survive
stomach and intestinal digestive enzymes, can undergo
bacteria fermentation in the colon to release bioactive
compounds [7,25,37]. HPLC analysis of the phenolic
extracts (free and bound) of white butterfly leaf revealed
that flavonoids (quercetin, rutin and kaempferol) andiversity for Science 10 (2016) 521–533
phenolic acids (chlorogenic and caffeic acids) are the
major components of the extract. Hence, we hypothesize
that the abundance of flavonoids and phenolic acids in
white butterfly leaf extract could be a biochemical ratio-
nale of their biological effects of the extracts as observed
in the enzyme inhibition studies.
Previous studies have established the link between
the pathogenesis and complications of diabetes, hyper-
tension and other cardiovascular diseases with free
radical formation [28,38,39]. Vascular dysfunction asso-
ciated with hyperglycemia has been reportedly triggered
by reactive oxygen species (ROS) produced in the
mitochondria electron transport chain [25,37,40]. Free
radical-induced oxidative damage to blood vessel’s
endothelia cells could compromise the elasticity of
the vessel, resulting in hypertension or some other
cardiovascular complication [41,42]. Plant bioactive
compounds, such as phenolics, have been shown to be
effective in the prevention and management of diabetes
and hypertension [41,43,44] by antioxidant mechanisms
that prevent free radical generation, scavenge free radi-
cals and chelate transition metal ions. In many reports,
the antioxidant activities of several plant parts have been
directly linked to their phenolic content [6,24,29,45].
Therefore, this study investigated the free radical scav-
enging and chelating abilities of phenolic extracts (free
and bound) of white butterfly leaf.
One of the antioxidant indices is the DPPH free rad-
ical scavenging ability. DPPH abstracts hydrogen or
electrons from stable molecules, turning them into free
radicals, and it becomes a stable diamagnetic molecule
[17,24]. Therefore, phenolics and flavonoids scavenge
DPPH by donating electrons or hydrogen to stabilize the
radical. Our investigation revealed that free soluble and
bound phenolic extracts of white butterfly leaf scavenged
DPPH free radicals in a concentration dependent man-
ner (0–83.3 g/mL). Actually, the free soluble phenolics
(IC50 = 89.18 g/mL) showed a significantly (P  < 0.05)
higher radical scavenging ability than the bound phen-
olics (IC50 = 133.40 g/mL). Interestingly, the DPPH
radical scavenging abilities of the phenolic extracts (free
and bound) correlates with the total phenolic and total
flavonoid contents of the leaf. Hence, the observed DPPH
radical scavenging ability could be attributed to the abun-
dant phenols and flavonoids in the extracts.
The hydroxyl radical is a highly reactive free radical
that is capable of damaging all types of biomolecules.
It is mostly generated by the reaction between H2O2
and a transition metal catalyst, with iron gaining promi-
nence for its abundant endogenous distribution [46].
This highly reactive free radical can cause peroxida-
tion of membrane lipids and damage to DNA. Hence,
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cavenging hydroxyl radicals will be a useful way to
revent the damage done to biomolecules. Therefore,
his study investigated the hydroxyl radical scaveng-
ng ability of the phenolic extracts (free and bound)
f the white butterfly leaf. Both the free soluble and
ound phenolic extracts significantly (P  < 0.05) scav-
nged hydroxyl radicals in a concentration dependent
anner (0–708.3 g/mL). However, the free soluble
henolic extracts (IC50 = 924.90 g/mL) showed a sig-
ificantly (P  < 0.05) higher scavenging ability than the
ound phenolic extract (IC50 = 1224.00 g/mL). This
esult also agrees with the DPPH radical scavenging
bility of the phenolic extract. Because this result corre-
ates with the total phenolic content of the leaf extract,
he hydroxyl radical scavenging ability of the phenolic
xtracts can be attributed to the abundant phenolic con-
ent and represents one of the antioxidant mechanisms
f the white butterfly leaf. The free radical (DPPH and
H) scavenging ability of the phenolic extracts of the
hite butterfly leaf agrees with earlier findings on the
ree radical scavenging abilities of phenolic extracts of
lack pepper [29].
Furthermore, chelating iron could help prevent the
eneration of hydroxyl radicals. Iron serves as a metal
atalyst in producing hydroxyl radicals from hydro-
en peroxide [46]. The ability of the free soluble and
ound phenolic extracts of the white butterfly to chelate
e2+ was investigated. The phenolic extracts (free
nd bound) significantly chelate Fe2+ in a concentra-
ion dependent manner (0–80 g/mL). The free soluble
henolics (IC50 = 146.90 g/mL) showed a significantly
igher chelating ability than the bound phenolic extracts
IC50 = 641.70 g/mL). By chelating Fe2+, the genera-
ion of hydroxyl radicals in the Fenton reaction can be
ttenuated and thus prevent possible damage of hydroxyl
adicals to biomolecules. Accumulation of iron has been
eported to lead to an increase in free radicals and devel-
pment of oxidative stress [24]. One of the consequences
f oxidative stress is the initiation of lipid peroxida-
ion by free radicals via  the oxidation of polyunsaturated
atty acids in biomembranes. This reaction is catalyzed
y Fe2+. Lipid peroxidation, characterized by elevated
alondialdehyde (MDA) production, has been previ-
usly reported in the pancreatic tissue homogenate of
iabetic animal models [47,48]. Accumulation of Fe2+
n the acinar cells and islets of Langerhans of the pan-
reas results in the membrane lipid peroxidation and
estruction of beta-cells associated with insulin produc-
ion [49]. Similarly, end products of lipid peroxidation,
uch as malondialdehyde (MDA) and 4-hydroxynonenal
HNE), are capable of damaging proteins by cova-
ent modification [50]. The ability of plan phenoliciversity for Science 10 (2016) 521–533 531
extracts to inhibit Fe2+ induced lipid peroxidation in  vitro
has been previously reported [25]. Therefore, the abil-
ity of the phenolic extracts (free and bound) of the
white butterfly leaf to inhibit Fe2+ induced lipid per-
oxidation in  vitro  was investigated. The free soluble
and bound phenolic extracts inhibited lipid peroxida-
tion marked by a significant (P  < 0.05) reduction in the
MDA content (free soluble phenolic = 192.30–77.90%;
bound phenolic = 192.30–91.30%). The ability of the
phenolic extracts to inhibit lipid peroxidation induced
by Fe2+ could be associated with their phenolic con-
stituents by forming structural complexes with Fe2+,
thus chelating it from initiating the lipid peroxidation
chain reaction. Therefore, this could further explain the
biochemical mechanism underlying the use of white
butterfly leaf for the treatment of DM in traditional
medicine.
Sodium nitroprusside (SNP) is a peripheral vasodila-
tor that elicits its blood pressure lowering effect by direct
action on smooth muscle fibres of blood vessels [51].
This vasodilation effect is proposed to be due to the
release of nitric oxide (NO) from SNP [7]. In addi-
tion, the contraction mediated glucose uptake pathway
essentially utilizes NO as a signalling molecule [7]. Nev-
ertheless, SNP has been linked to cytotoxicity as a result
of the release of NO and cyanide [7]. At a high concentra-
tion, NO is capable of reacting with other reactive oxygen
species to form peroxyl nitrite radicals [8,52]. Similarly,
decomposition of SNP yields iron, which is capable of
propagating the lipid peroxidation chain reaction [53].
Therefore, this study further sought to investigate the
inhibition of SNP-induced lipid peroxidation in pan-
creatic tissue homogenates of rats by phenolic extracts
(free and bound) of the white butterfly leaf. The induc-
tion of lipid peroxidation in the rat pancreas incubated
with 7 M SNP (marked by a significant (P  < 0.05) ele-
vated MDA content 134.70%) was effectively reversed
by the phenolic extracts (free = 134.70–66.50% and
bound = 134.70–81.70%) in a dose dependent manner
(0–312.60 g/mL). This result is in agreement with pre-
vious findings [7,54] and correlates with the inhibitory
effects of the phenolic extracts (free and bound) on
Fe2+-induced lipid peroxidation. The ability of the phe-
nolic and flavonoid constituents of the phenolic extracts
to scavenge the reactive peroxyl nitrite radicals and/or
chelate iron released by SNP could be a possible mecha-
nism of the observed inhibition of lipid peroxidation and
hence the anti-hyperglycaemic and anti-hypertensive
effects of white butterfly leaf, as reported in folklore
medicine. Furthermore, the ability of phenolic phyto-
chemicals to scavenge free radicals and chelate transition
metal ions has been well reported [55].
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5.  Conclusion
From the findings of this study, it can be concluded
that the phenolic extracts (free and bound) of the white
butterfly leaf inhibit alpha amylase and alpha glucosidase
(key enzymes linked to NIDDM) as well as angiotensin-1
converting enzyme (key enzyme linked to hypertension)
in vitro. Similarly, both free soluble and bound phe-
nolic extracts have antioxidant and lipid peroxidation
inhibitory activities. These findings could help explain
the biochemical rational behind the use of white butter-
fly leaf in the prevention and management of NIDDM
and hypertension in traditional medicine. Hence, the
data generated seem promising and present white but-
terfly leaf as a natural alternative in the management of
NIDDM and hypertension.
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